Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

© 2014 American Society for Blood and Marrow Transplantation. Improving outcomes among class 3 thalassemia patients receiving allogeneic hematopoietic stem cell transplantations (HSCT) remains a challenge. Before HSCT, patients who were ≥ 7 years old and had a liver size ≥ 5 cm constitute what the C...

Full description

Saved in:
Bibliographic Details
Main Authors: Usanarat Anurathapan, Samart Pakakasama, Pimsiri Mekjaruskul, Nongnuch Sirachainan, Duantida Songdej, Ampaiwan Chuansumrit, Pimlak Charoenkwan, Arunee Jetsrisuparb, Kleebsabai Sanpakit, Bunchoo Pongtanakul, Piya Rujkijyanont, Arunotai Meekaewkunchorn, Rosarin Sruamsiri, Artit Ungkanont, Surapol Issaragrisil, Borje S. Andersson, Suradej Hongeng
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/34814
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/34814

Similar Items